MyAlcon Professional Logo
Online Store
MyAlcon for Consumers

My Alcon | United Kingdom

This page is available in English. Select below for other locations.

Select Another Location

AutonoMe®

Delivery System

 

Control at every step1

AutonoMe® Delivery System

 

Control at every step1

 

AutonoMe® is the first and only automated, disposable, pre-loaded IOL delivery system.

 

Intuitive Control for a Smooth IOL Delivery1-3 

Circle with a partially blue border with the remaining part of the border coloured as grey. Text in the middle of the circle reads “68 percent”, to describe the percentage of surgeons that found the delivery speed easy to control with this device. Close up shot of the AutonoMe Delivery System’s speed control lever is to the right of the circle.
Circle with a partially blue border with the remaining part of the border coloured as grey. Text in the middle of the circle reads “68 percent”, to describe the percentage of surgeons that found the delivery speed easy to control with this device. Close up shot of the AutonoMe Delivery System’s speed control lever is to the right of the circle.

68% of surgeons found the delivery speed easy to control2*

 

The responsive speed control lever2
 
  • Provides full control of plunger advancement
  • Allows surgeons to precisely start, stop and linearly adjust speed at any time during surgery
  • Helps surgeons focus more on the patient
Circle with a partially blue border with the remaining part of the border coloured as grey. Text in the middle of the circle reads “70 percent”, to describe the percentage of surgeons that rated the overall experience of AutonoMe as smooth and effortless. Close up shot of the AutonoMe Delivery System’s inner spring sits on the left of the circle.
Circle with a partially blue border with the remaining part of the border coloured as grey. Text in the middle of the circle reads “70 percent”, to describe the percentage of surgeons that rated the overall experience of AutonoMe as smooth and effortless. Close up shot of the AutonoMe Delivery System’s inner spring sits on the left of the circle.

70% of surgeons rated the overall experience of AutonoMe® as smooth and effortless2†

 

A unique delivery mechanism2,3

 

  • Smooth, automated IOL delivery of up to 3 mm/sec
  • Steady and continual motion providing a new level of control over IOL delivery speed

* Ease of controlling plunger advancement during IOL delivery; percent of total participants (n=136) from US, EU, Brazil & Japan. Study was conducted with porcine cadaver eyes (6 eyes per participant with over 800 eyes in total).  
† Surgeons most commonly answered “Smooth” (43%) and “Effortless” (27%). Percent of total participants n=136 participants from US, EU, Brazil & Japan. Study was conducted with porcine cadaver eyes (6 eyes per participant with over 800 eyes in total).

Designed to fit comfortably in surgeons’ hands for intuitive single-handed control of the device1-3

 

  • Designed for a natural fit to suit multiple surgical techniques, with no injection force required

 

  • Single-handed design frees the second hand for globe stabilisation

 

  • Precise control of nozzle tip orientation allows for consistent delivery of the IOL into the capsular

Designed to fit comfortably in surgeons’ hands for intuitive single-handed control of the device1-3

 

  •  Designed for a natural fit to suit multiple surgical techniques, with no injection force required

 

  • Single-handed design frees the second hand for globe stabilisation

 

  • Precise control of nozzle tip orientation allows for consistent delivery of the IOL into the capsular

 

Preserves Wound Integrity4*

AutonoMe® features a proprietary depth guard1,4

  • Allows reduced stress and damage to the surrounding tissue
  • Control of nozzle insertion depth
  • Minimised incision enlargement
  • Greater resistance to nozzle tip splitting
  • Precise delivery into the capsular bag

 

 

*Ex-vivo, exploratory laboratory study performed on 32 human cadaver eyes.

Close up shot of the AutonoMe nozzle tip in front of a black background. A blue circle is placed over the device to draw attention to the nozzle tip.

The AutonoMe® nozzle tip is designed to maintain wound integrity by5

  • Preserving corneal tissue
  • Minimising damage to Descemet’s membrane
Two related images beside each other. The first image is a close-up of the AutonoMe nozzle tip, with text indicating that the length of the tip is 3.0mm, and diameter of the tip is 2.0mm. Blue text at the top of this image reads “Nozzle Tip Dimensions.” The second image is of the pre- and post- implantation process for AutonoMe, Vivinex, and Tecnis. Blue text at the top of this image reads “OCT images of post-implantation incisions ex vivo.” Red arrows on top of the Vivinex and Tecnis images point to membrane tearing post implantation ex vivo.

 * Study conducted on human cadaver eyes that were randomly assigned to receive IOLs implanted with the preloaded delivery devices.
† Trademarks are the property of their respective owners

AutonoMe® demonstrates the lowest incidence of Descemet’s membrane detachment, compared to other delivery systems5

Bar graph illustrates the “the percentage of Descemet’s membrane detachment ex vivo in human cadaver eyes.” AutonoMe reports the lowest occurrence of 6.25 percent, while Vivinex iSert and iTec reports 25 and 43.75, respectively. The difference between AutonoMe and iTec was statically significant.

* Trademarks are the property of their respective owners. 
† Denotes a statistically significant difference (p=0.037) from AutonoMe® using a Fisher’s exact test.​

Easier to Use than Competitor Devices

 

AutonoMe® is reported to be easier to use compared to iTec* and iSert*2†

AutonoMe Delivery System in between two blue circles. The circle on the left is visually representing 80 percent. White text underneath this circle reads “80% of surgeons reported AutonoMe as easier to use vs. iTec.” The circle on the right is visually representing 64 percent. White text underneath this circle reads “64% of surgeons reported AutonoMe as easier to use vs. Vivinex iSert.”

* Trademarks are the property of their respective owners. 
† Porcine whole eye globes were used as the model in this study, as this model is extensively used for cataract surgery and IOL implantation studies.
Based on n = 17 for iTec and n = 8 for iSert.

AutonoMe® is ready to use in 3 simple steps1

Illustration of the AutonoMe Delivery System. A black arrow points towards the device with text that reads “Viscoelastic Port.” A second black arrow points towards the nozzle tip with text that reads “Fill viscoelastic to nozzle tip.”

Illustration of an AutonoMe Delivery System’s plunger/cartridge piece. A dark blue arrow points towards the folded IOL in the AutonoMe cartridge with text that reads “Pause Location.”

Illustration of a hand holding an AutonoMe Delivery System. A black arrow points towards the device to indicate a pushing down movement.

Learn how to use the

AutonoMe® Delivery System.

 
 

AutonoMe® is Pre-Loaded with

Clareon® IOL 

 

Clareon® IOL offers outstanding refractive outcomes and unsurpassed clarity that lasts.6-14

Learn More About Clareon® IOL

AutonoMe® is Pre-Loaded with Clareon® IOL 

 

Clareon® IOL offers outstanding refractive outcomes and unsurpassed clarity that lasts.6-14

 

Learn More About Clareon® IOL

 

AutonoMe Clinical Studies

    Liu J, Wolfe P, Hernandez V & Kohnen T. Comparative assessment of the corneal incision enlargement of 4 preloaded IOL delivery systems

    Comparing the corneal incision size enlargement after intraocular lens (IOL) implantation of a new, automated, preloaded delivery system, AutonoMe, vs that of 3 other available preloaded systems (UltraSert, Vivinex iSert, and Tecnis iTec)

    Yildirim TM, Labuz G, Baur ID, et al. Corneal incision enlargement in two preloaded intraocular lens injectors: An intraindividual in vivo study

    Assessing enlargement of the clear corneal incision site and functional outcome in patients with cataract, following the use of two preloaded intraocular lens (IOL) injectors

    Oshika T & Sasaki N. Experimental study on delivery performance of an automated preloaded intraocular lens injector system for corneal and sclerocorneal incisions

    Evaluating delivery performance of an automated preloaded intraocular lens (IOL) injector systems (AutonoMe) in the porcine eyes

    Technical Specifications1

    table

    Instructions for Use (IFU)

     

    For a full list of indications, contraindications and warnings, please visit ifu.alcon.com and refer to the relevant product’s instructions for use.

    Visit IFU Database

    Alcon Experience Academy

     

    For relevant training content from industry thought leaders

    Visit AEA Portal
      References

      1.Clareon® AutonoMe® Directions for Use. 
      2.Nozzle Preference and Delivery System Performance Study between AutonoMe and UltraSert V3.5 - TDOC 0053876 
      3.Verification Report, IOL Inserter Plunger Speed Testing. Alcon internal document REF-04194. 
      4.Liu J, Wolfe P, Hernandez V, Kohnen T. Comparative assessment of the corneal incision enlargement of 4 preloaded IOL delivery systems. J Cataract Refract Surg. 2020 Jul;46(7):1041-1046. 
      5.Alcon Data on File. TDOC-0054429. 
      6.Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL. J Cataract Refract Surg. 2019;45:1490-1497.  
      7.Clareon® IOL Directions for Use.  
      8.Alcon Data on File, 2017. [TDOC-0050244] 
      9.Alcon Data on File, 2017. [TDOC-0054028] 
      10.Alcon Data on File, 2017. [TDOC-0053564] 
      11.Alcon Data on File, 2017. [TDOC-0053584] 
      12.Alcon Data on File, 2020. [TDOC-0057291] 
      13.Stanojcic N, O’Brart D, Hull C, et al. Visual and refractive outcomes and glistenings occurrence after implantation of 2 hydrophobic acrylic aspheric monofocal IOLs. J Cataract Refract Surg. 2020;46(7):986-994. 
      14.Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate.  J Cataract Refract Surg. 2020;46(5):682-687. 
       

      Please refer to the relevant product direction for use for list of indications, contraindications and warnings. Find at https://ifu.alcon.com

      ©2022 Alcon Inc. 04/22 UKIE-CLA-2200001

      United Kingdom
      Alcon See Brilliantly Logo